(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADVANTAGE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADVANTAGE

ST13

US500000075134372

Class

1

Filing

75134372

Registration

2061530

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

08/11/2026

Trademark type

Word

Nice classes

1

Filing date

07/15/1996

Registration date

05/13/1997

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/17/2026

Last transaction

08/11/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

07/19/1995

First use in commerce

07/19/1995

Drawing code

1

Owner type

03

Owner location

San Jose, CA, US

Examiner

WELLS, KELLEY L

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TAKARA BIO USA, INC.
Clontech Laboratories, Inc.
Clontech Laboratories, Inc.

Representatives

Bret E. Field Bozicevic, Field & Francis LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

reagents used in molecular biology proceduresenzymesnucleic acidsnucleotidesbufferssolutions that include the samefor use in polymerase chain reaction (PCR) and PCR-related proceduresPCR sample preparationpurificationpost-PCR cloning of amplification productsthe like; and kits that include the reagentssolutionsother materials for carrying out said PCR or PCR-related procedures

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/17/2026

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

07/17/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/17/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/17/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

05/15/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/03/2016

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/03/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/03/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/17/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

06/14/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/14/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/13/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/18/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/09/2007

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/09/2007

PLGL

ASSIGNED TO PARALEGAL

06/09/2007

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

05/10/2007

E89R

TEAS SECTION 8 & 9 RECEIVED

05/10/2007

CFIT

CASE FILE IN TICRS

12/08/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/23/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/06/2003

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/21/2003

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

04/29/2003

E815

TEAS SECTION 8 & 15 RECEIVED

04/28/2003

R.PR

REGISTERED-PRINCIPAL REGISTER

05/13/1997

PUBO

PUBLISHED FOR OPPOSITION

02/18/1997

NPUB

NOTICE OF PUBLICATION

01/17/1997

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/12/1996

DOCK

ASSIGNED TO EXAMINER

12/12/1996

Continuous trademark protection

Get notified about every new filing that threatens ADVANTAGE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.